Norac Pharma

Norac Pharma offers value-added outsourcing services for complex and demanding molecules. A world-class scientific team is dedicated to R&D necessary for rapid evolution of APIs from early-IND through sustained cGMP production.

Custom Synthesis
Process development
Small Scale cGMP
Large Scale cGMP
Advanced Technologies
Analytical Services
Regulatory Support

Activity:

- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Manufacturing
- Research & Development
- Other Industry Services

Product / Technology type(s) covered:

- API / chemicals

Therapeutic targets:

- AIDS
- Alzheimer's Disease
- Arthritis / Rheumato
- Cancer
- Central nervous system
- Dermatology
- Mental Health
- Neurology
- Oncology
- Pain
- Reproductive Health

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Europe , Australia/New-Zealand , Far East , Asia , Central/South America , Far East , Near/Middle East

c. Countries active: United States, European Union, Japan. Manufacturing locations in the U.S. and Europe

Corporate data:

Number of Employees: 125

Turnover:

Amount:	Year:	Currency:
50 Million	2002	US Dollar

Year founded: 1954